GOUT-36预测规则用于共病痛风患者院内痛风发作:推导与外部验证
该研究基于新西兰625例因非痛风疾病住院的共病痛风患者队列推导出GOUT-36规则,含四项预测因子,两项及以上为高风险;在泰国和中国284例前瞻性队列中验证,敏感度75%、特异度67%、AUC 0.71,并划分低、中、高、极高风险四组。
要点
- GOUT-36规则含四项:入院前未用痛风发作预防、未用降尿酸治疗、痛风石、既往一年血尿酸>0.36 mmol/l。
- 两项及以上为高风险,验证队列敏感度75%、特异度67%、AUC 0.71。
- 极高风险组80%发生院内痛风发作,低风险组仅11%。
核心结论
- GOUT-36规则简单且敏感,可用于对共病痛风住院患者进行院内痛风发作高风险分类,辅助临床决策和未来预防研究。
研究设计与样本
- 预测规则从新西兰625例因非痛风疾病住院的共病痛风患者队列中推导。
- 规则在泰国和中国284例共病痛风住院患者的前瞻性队列中进行外部验证。
主要发现
- GOUT-36规则分类院内痛风发作高风险的敏感度为75%、特异度为67%、曲线下面积为0.71。
- 规则划分四组:低风险(零项)、中风险(一项)、高风险(两项)、极高风险(三或四项)。
- 在院内痛风发作总体发生率34%的人群中,极高风险组80%发生院内发作,低风险组11%发生院内发作。
关键数值与推荐
- GOUT-36规则四项:入院前无痛风发作预防、入院前无降尿酸治疗、痛风石、既往一年内血尿酸>0.36 mmol/l。
- 两项及以上条目阳性定义为院内痛风发作高风险。
临床怎么用
- 可对因非痛风疾病住院的共病痛风患者应用GOUT-36规则进行风险分层,识别高风险者以辅助临床决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To develop and validate a gout flare risk stratification tool for people with gout hospitalized for non-gout conditions. METHODS: The prediction rule for inpatient gout flare was derived from a cohort of 625 hospitalized people with comorbid gout from New Zealand. The rule had four items: no pre-admission gout flare prophylaxis, no pre-admission urate-lowering therapy, tophus and pre-admission serum urate >0.36 mmol/l within the previous year (GOUT-36 rule). Two or more items are required for the classification of high risk for developing inpatient gout flares. The GOUT-36 rule was validated in a prospective cohort of 284 hospitalized people with comorbid gout from Thailand and China. RESULTS: The GOUT-36 rule had a sensitivity of 75%, specificity of 67% and area under the curve of 0.71 for classifying people at high risk for developing inpatient gout flares. Four risk groups were developed: low (no items), moderate (one item), high (two items) and very high risk (three or four items). In a population with frequent (overall 34%) in-hospital gout flares, 80% of people with very high risk developed inpatient flares while 11% with low risk had inpatient flares. CONCLUSION: The GOUT-36 rule is simple and sensitive for classifying people with high risk for inpatient gout flares. The rule may help inform clinical decisions and future research on the prevention of inpatient gout flares.
引用
- Jatuworapruk K, Grainger R, Dalbeth N, et al. The GOUT-36 prediction rule for inpatient gout flare in people with comorbid gout: derivation and external validation. Rheumatology (Oxford). 2022. PMID: 34297058. doi:10.1093/rheumatology/keab590
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。